Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
618 A novel preclinical mouse model to investigate IL-18-targeting therapies
4 affiliations
- 1geOway, Lyon, Rhône-Alpes, France
- 2GenOway, Lyon, France
- 31genOway, Lyon, France
- 42genOway, Rhone Alpes, France
Related
- Cortical dynamics in Angelman syndrome: novel insights from a preclinical mouse model
- A Novel Computational Framework to Investigate the Biomechanics of Burrowing
- KLHL40 gene replacement therapy in severe nemaline myopathy improves survival and skeletal muscle function in a preclinical mouse model
- Characterization of the knock-in AppSAA mouse model as a powerful tool for Alzheimer's disease preclinical research.
- Differential Adaptation of Osteocyte Lacunar Morphology at Bone (Re)modeling Sites under Mechanical Loading and Pharmacological Therapies in a Mouse Model of Osteoporosis
BibTeX
@article{martin2026novel,
title = {{618 A novel preclinical mouse model to investigate IL-18-targeting therapies}},
author = {Gaëlle Martin and Fabiane Sônego and Patricia Isnard-Petit and Kader Thiam and Angela Pappalardo},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0618},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0618},
note = {CC BY},
}
RIS
TY - JOUR
TI - 618 A novel preclinical mouse model to investigate IL-18-targeting therapies
AU - Gaëlle Martin
AU - Fabiane Sônego
AU - Patricia Isnard-Petit
AU - Kader Thiam
AU - Angela Pappalardo
PY - 2026
DA - 2026/11/04
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0618
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0618
SN - 2051-1426
ER -